| Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade PJ Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, ... Journal of Clinical Oncology 33 (6), 550, 2015 | 2223 | 2015 |
| Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection J Dinnes, P Sharma, S Berhane, SS van Wyk, N Nyaaba, J Domen, ... Cochrane database of systematic reviews, 2022 | 1702 | 2022 |
| Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 T Struyf, JJ Deeks, J Dinnes, Y Takwoingi, C Davenport, MMG Leeflang, ... Cochrane database of systematic reviews, 2022 | 963 | 2022 |
| Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection AWH Chan, J Zhong, S Berhane, H Toyoda, A Cucchetti, KQ Shi, T Tada, ... Journal of hepatology 69 (6), 1284-1293, 2018 | 396 | 2018 |
| Thoracic imaging tests for the diagnosis of COVID‐19 N Islam, S Ebrahimzadeh, JP Salameh, S Kazi, N Fabiano, L Treanor, ... Cochrane Database of Systematic Reviews, 2021 | 338 | 2021 |
| The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers PJ Johnson, SJ Pirrie, TF Cox, S Berhane, M Teng, D Palmer, J Morse, ... Cancer Epidemiology, Biomarkers & Prevention 23 (1), 144-153, 2014 | 290 | 2014 |
| Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients S Berhane, H Toyoda, T Tada, T Kumada, C Kagebayashi, S Satomura, ... Clinical Gastroenterology and Hepatology 14 (6), 875-886. e6, 2016 | 276 | 2016 |
| GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis J Best, LP Bechmann, JP Sowa, S Sydor, A Dechêne, K Pflanz, S Bedreli, ... Clinical gastroenterology and hepatology 18 (3), 728-735. e4, 2020 | 222 | 2020 |
| Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade H Toyoda, P Lai, J O'Beirne, CC Chong, S Berhane, H Reeves, D Manas, ... British journal of cancer 114 (7), 744-750, 2016 | 178 | 2016 |
| Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: a meta-analysis of randomized phase III trials R Jackson, EE Psarelli, S Berhane, H Khan, P Johnson Journal of Clinical Oncology 35 (6), 622-628, 2017 | 160 | 2017 |
| Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response‐based approach G Han, S Berhane, H Toyoda, D Bettinger, O Elshaarawy, AWH Chan, ... Hepatology 72 (1), 198-212, 2020 | 108 | 2020 |
| Child–Pugh Classification: Time to Abandon? B Kok, JG Abraldes Seminars in liver disease 39 (01), 096-103, 2019 | 89 | 2019 |
| Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma JC Steele, A Rao, JR Marsden, CJ Armstrong, S Berhane, LJ Billingham, ... Gene therapy 18 (6), 584-593, 2011 | 82 | 2011 |
| Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion I Waked, S Berhane, H Toyoda, SL Chan, N Stern, D Palmer, T Tada, ... British journal of cancer 116 (4), 448-454, 2017 | 81 | 2017 |
| Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model R Fox, S Berhane, M Teng, T Cox, T Tada, H Toyoda, T Kumada, ... British journal of cancer 110 (8), 2090-2098, 2014 | 64 | 2014 |
| S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study YS Elhassan, B Altieri, S Berhane, D Cosentini, A Calabrese, ... European Journal of Endocrinology 186 (1), 25-36, 2022 | 58 | 2022 |
| PALBI-an objective score based on platelets, albumin & bilirubin stratifies HCC patients undergoing resection & ablation better than Child's classification S Roayaie, G Jibara, S Berhane, P Tabrizian, JW Park, J Yang, L Yan, ... Hepatology 62, 631A-632A, 2015 | 56 | 2015 |
| Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance P Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, R Fox, ... British journal of cancer 116 (4), 441-447, 2017 | 53 | 2017 |
| Validation of a model for identification of patients with compensated cirrhosis at high risk of decompensation IN Guha, R Harris, S Berhane, A Dillon, L Coffey, MW James, A Cucchetti, ... Clinical Gastroenterology and Hepatology 17 (11), 2330-2338. e1, 2019 | 45 | 2019 |
| The chances of hepatic resection curing hepatocellular carcinoma A Cucchetti, J Zhong, S Berhane, H Toyoda, KQ Shi, T Tada, CCN Chong, ... Journal of hepatology 72 (4), 711-717, 2020 | 42 | 2020 |
